Related references
Note: Only part of the references are listed.被撤回的出版物: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma(Retracted article. See vol.54,pg.2380,2017)
Baoyu Lv et al.
MOLECULAR NEUROBIOLOGY (2015)
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
N. M. A. White et al.
BRITISH JOURNAL OF CANCER (2014)
An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
Pengfei Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
Neus Martinez-Bosch et al.
CANCER RESEARCH (2014)
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri et al.
CANCER TREATMENT REVIEWS (2014)
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
Anna Sophie Berghoff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2014)
Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
Jay S. Desgrosellier et al.
DEVELOPMENTAL CELL (2014)
Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer
Chang-Shuo Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Integrin β3 links therapy resistance and cancer stem cell properties
Nagarajan Kannan et al.
NATURE CELL BIOLOGY (2014)
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Laetitia Seguin et al.
NATURE CELL BIOLOGY (2014)
MEK in cancer and cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
P. Zhang et al.
CELL DEATH & DISEASE (2014)
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
Hannah van Malenstein et al.
CANCER LETTERS (2013)
Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
Ya-Ling Hsu et al.
CARCINOGENESIS (2013)
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Yulong Shang et al.
CURRENT CANCER DRUG TARGETS (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
Overexpression of Forkhead Box C1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma
Limin Xia et al.
HEPATOLOGY (2013)
B-crystallin complexes with 14-3-3 to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
Xiao-Yong Huang et al.
HEPATOLOGY (2013)
miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma
Zhong-Hua Tao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Bo Zhai et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito et al.
CANCER AND METASTASIS REVIEWS (2012)
CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial-Mesenchymal Transition in HCC Cells
Ai-Wu Ke et al.
GASTROENTEROLOGY (2011)
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
Zhiwei Wang et al.
DRUG RESISTANCE UPDATES (2010)
Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion
Wei Ding et al.
HEPATOLOGY (2010)
The evasive promise of antiangiogenic therapy
Jean-François Dufour
JOURNAL OF HEPATOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systemic therapy of advanced hepatocellular carcinoma: How hopeful should we be?
Andrew X. Zhu
ONCOLOGIST (2006)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Hepatocellular carcinoma: Current management and future trends
BI Carr
GASTROENTEROLOGY (2004)
Share Paper
